Skip to main content
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance

Steering Group

ENCePP Steering Group

The ENCePP Steering Group (SG) was established in 2010 to oversee the mid to long-term implementation of ENCePP. The Steering Group consists of 20 members with a balance of expertise and experience (regulatory, conduct of pharmacoepidemiological studies, patients, healthcare professionals, ethical issues). Six members of the Steering Group are elected representatives from the ENCePP Plenary. From 2014 onwards, the term of service of the Steering Group is three years.

The ENCePP Steering Group defines and safeguards the objectives and principles of ENCePP and decides on operational tasks of the network. The Steering Group is the highest authority of ENCePP and thus is its final decision making body. It acts as adjudicator in case of discrepancies or complaints in the context of the ENCePP network.

Document icon
General publications27 June 2024
Mandate of the ENCePP Steering Group - June 2024

 

Composition of the ENCePP SG 2024-2026

NameAffiliationRepresenting
Helga Gardarsdottir (Co-chair)Utrecht University, the NetherlandsENCePP partners
Catherine Cohet (Co-chair)European Medicines Agency, Data Analytics and Methods Task Force, the NetherlandsEMA
Alejandro AranaRTI Health Solutions, SpainENCePP partners
Annalisa LandiTEDDY European Network of Excellence for Paediatric Clinical Research, ItalyENCePP partners
Christos KontogiorgisDemocritus University of Thrace, Laboratory of Hygiene and Environmental Protection, GreeceENCePP partners
Marco TuccoriUniversity hospital of Pisa, Unit of adverse drug reactions monitoring UADRM, ItalyENCePP partners
Vera EhrensteinAarhus University, Department of Clinical Epidemiology, DenmarkENCePP partners
Annette Cleveland NielsenDanish Medicines Agency, DenmarkHMA
Carla TorreUniversity of Lisbon, PortugalCHMP, MWP
Frauke Naumann-WinterFederal Institute for Drugs and Medical DevicesGermanyCOMP
Hedvig Marie Egeland NordengNorwegian Institute Of Public HealthPRAC
Iryna VlasenkoEuropean Chapter of the International Diabetes Federation, BelgiumPCWP
Arnold K. ChanTriNetX, USAISPE
Gianluca TrifiròUniversity of Verona, Department of Diagnostics and Public Health, ItalyISoP
Laura PizziInternational Society for Pharmacoeconomics and Outcomes Research, USAISPOR
Craig SimonHealth Canada, CanadaHealth Canada
Hui-Lee WongU.S. Food and Drug Administration, USAFDA
Gianmario CandoreBayer, GermanyIndustry
Nadia AmaoucheEuropean Medicines Agency, Human Medicines Division, the NetherlandsEMA
Thomas GoedeckeEuropean Medicines Agency, Human Medicines Division, the NetherlandsEMA

 

EMAEuropean Medicines Agency
HMAHeads of Medicines Agencies
CHMPCommittee for Medicinal Products for Human Use
COMPCommittee for Orphan Medicinal Products
PRACPharmacovigilance Risk Assessment Committee
PCWPPatients' and Consumers' Working Party
ISPEInternational Society for Pharmacoepidemiology
ISoPInternational Society of Pharmacovigilance
ISPORInternational Society for Pharmacoeconomics and Outcomes Research (The professional society for health economics and outcomes research)
FDAFood and Drug Administration
MWPMethodological Working Party

Previous Steering Groups

doc_icon
General publications10 December 2018
Composition of Steering Group 2017-2019
doc_icon
General publications23 August 2016
Composition of Steering Group 2014-2016
doc_icon
General publications27 February 2013
Composition of Steering Group 2012-2013
doc_icon
General publications1 February 2010
Composition of Steering Group 2010-2011

Steering Group Meeting Reports